Literature DB >> 29157856

Susceptibility-Weighted Imaging and Magnetic Resonance Spectroscopy in Concussion.

Ivan I Kirov1, Christopher T Whitlow2, Carlos Zamora3.   

Abstract

Although susceptibility-weighted imaging (SWI) studies have suggested an increased number of microhemorrhages in concussion, most show no significant differences compared with controls. There have been mixed results on using SWI to predict neurologic outcomes. Drawbacks include inability to time microhemorrhages and difficulty in attributing them to the concussion. Magnetic resonance spectroscopy (MRS) in concussion can identify metabolic abnormalities, with many studies showing correlations with clinical outcome. Applications in individual patients are impeded by conflicting data and lack of consensus on an optimal protocol. Therefore, currently MRS has most utility in group-level comparisons designed to reveal the pathophysiology of concussion.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Concussion; Magnetic resonance spectroscopy (MRS); Mild traumatic brain injury (mTBI); SWI; Susceptibility-weighted imaging

Mesh:

Year:  2017        PMID: 29157856     DOI: 10.1016/j.nic.2017.09.007

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  8 in total

1.  A preliminary investigation of cognitive intolerance and neuroimaging among adolescents returning to school after concussion.

Authors:  John G Baker; Barry S Willer; Michael G Dwyer; John J Leddy
Journal:  Brain Inj       Date:  2020-04-23       Impact factor: 2.311

Review 2.  The Diagnosis and Management of Posttraumatic Headache with Associated Painful Cranial Neuralgias: a Review and Case Series.

Authors:  Paul G Mathew; Wade Cooper
Journal:  Curr Pain Headache Rep       Date:  2021-06-23

Review 3.  Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence.

Authors:  Alejandro Labastida-Ramírez; Silvia Benemei; Maria Albanese; Antonina D'Amico; Giovanni Grillo; Oxana Grosu; Devrimsel Harika Ertem; Jasper Mecklenburg; Elena Petrovna Fedorova; Pavel Řehulka; Francesca Schiano di Cola; Javier Trigo Lopez; Nina Vashchenko; Antoinette MaassenVanDenBrink; Paolo Martelletti
Journal:  J Headache Pain       Date:  2020-05-24       Impact factor: 7.277

4.  Pathological Insights From Quantitative Susceptibility Mapping and Diffusion Tensor Imaging in Ice Hockey Players Pre and Post-concussion.

Authors:  Alexander M Weber; Anna Pukropski; Christian Kames; Michael Jarrett; Shiroy Dadachanji; Jack Taunton; David K B Li; Alexander Rauscher
Journal:  Front Neurol       Date:  2018-08-06       Impact factor: 4.003

5.  The clinical utility of proton magnetic resonance spectroscopy in traumatic brain injury: recommendations from the ENIGMA MRS working group.

Authors:  Brenda L Bartnik-Olson; Jeffry R Alger; Talin Babikian; Ashley D Harris; Barbara Holshouser; Ivan I Kirov; Andrew A Maudsley; Paul M Thompson; Emily L Dennis; David F Tate; Elisabeth A Wilde; Alexander Lin
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

Review 6.  Noninvasive magnetic resonance imaging techniques in mild traumatic brain injury research and diagnosis.

Authors:  Ekaterina Lunkova; Guido I Guberman; Alain Ptito; Rajeet Singh Saluja
Journal:  Hum Brain Mapp       Date:  2021-08-24       Impact factor: 5.038

Review 7.  ENIGMA brain injury: Framework, challenges, and opportunities.

Authors:  Emily L Dennis; David Baron; Brenda Bartnik-Olson; Karen Caeyenberghs; Carrie Esopenko; Frank G Hillary; Kimbra Kenney; Inga K Koerte; Alexander P Lin; Andrew R Mayer; Stefania Mondello; Alexander Olsen; Paul M Thompson; David F Tate; Elisabeth A Wilde
Journal:  Hum Brain Mapp       Date:  2020-06-01       Impact factor: 5.038

8.  Susceptibility-Weighted Magnetic Resonance Imaging (MRI) of Microbleeds in Pediatric Concussion.

Authors:  Shane Virani; Alexander Barton; Bradley G Goodyear; Keith Owen Yeates; Brian L Brooks
Journal:  J Child Neurol       Date:  2021-05-08       Impact factor: 1.987

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.